ALB and metabolic dysfunction-associated steatotic liver disease: Concurrent declines in hepatic synthetic markers—albumin (Δ = −0.82 g/dL) and prealbumin (Δ = −2.74 mg/L)—mirror patterns observed in NAFLD progression (27), suggesting MetS exacerbates subclinical liver dysfunction.